iiinova — where your digital self keeps evolving

FFA Zulu

@ffaz.bsky.social

7 followers 13 following 14 posts

Investor, traveller, humanist. Sick of the shit.

Posts Replies Media

FFA Zulu @ffaz.bsky.social · 28/08/2025

@mdanderson.bsky.social can you provide a cohort 1 update for HG-CT-1 please? So far no HSCT? Will you present at #ASH?

000

FFA Zulu @ffaz.bsky.social · 15/05/2025

Hemogenyx Pharmaceuticals have filed for permission to treat children with AML, their ongoing HG-CT-1 is with MDA. The company could seriously do with assistance funding these trials. Company have been shorted making it almost impossible to raise reasonable levels of funding.

000

FFA Zulu @ffaz.bsky.social · 24/02/2025

Hi, do you see replies? Are you aware that Hemogenyx, sponsor of your HG-CT-1 trial are under a short attack from a well known trader accusing them of lying about the trial? At 12m mCap they are vulnerable. Any sort of coverage, even a tweet would help naming them.

000

FFA Zulu @ffaz.bsky.social · 20/02/2025

I hope Hemogenyx and HG-CT-1 will be part of the story treating pediatric patients with MD Anderson ❤️

000

FFA Zulu @ffaz.bsky.social · 08/01/2025

We need Chimeric Bait Receptor Platform from Hemogenyx.

000

FFA Zulu @ffaz.bsky.social · 08/01/2025

More interested in the Chimeric Bait Receptor Platform from Hemogenyx, why not partner/ fund research there??

000

FFA Zulu @ffaz.bsky.social · 24/12/2024

Eyes on Hemogenyx for Friday. It's going to be good #HEMO

000

FFA Zulu @ffaz.bsky.social · 15/12/2024

This week Hemogenyx Pharmaceuticals #hemo faces the world no longer a penny stock as they look to attract international investors. Clinical trials get underway imminently with their lead CAR-T candidate against AML.

000

FFA Zulu @ffaz.bsky.social · 22/11/2024

Congratulations to @mdanderson.bsky.social and Hemogenyx Pharmaceuticals as they announce IRB approval for Phase 1 trials of HG-CT-1 targeting AML #HEMO

000

FFA Zulu @ffaz.bsky.social · 21/11/2024

@mdanderson.bsky.social can you provide an update on the #hemo Clinical trial for HG-CT-1 targeting Acute Myeloid Leukemia AML due to launch THIS week? Very excited so would love to know when it goes live and brings Hemogenyx from preclinical to clinical!

000

FFA Zulu @ffaz.bsky.social · 16/11/2024

Evening for you is 9-5 somewhere in the world.....

010

FFA Zulu @ffaz.bsky.social · 16/11/2024

Can I suggest you checkout HG-CT-1, then look at their CDX and CBR treatment, extremely exciting but very early!

030

FFA Zulu @ffaz.bsky.social · 16/11/2024

Hi, first CAR-T post I have seen on blue sky, moving from twitter. Have you seen HG-CT-1 from Hemogenyx, trials to be launched this week, company very under the radar,worth covering. Initially AML however also targeting ALL and with their bispecific Lupus aswell!

061

FFA Zulu @ffaz.bsky.social · 16/11/2024

Any #hemo holders on here? So far none. I'll start. Hemogenyx are due to launch their first human trials for #AML cancer next week. Huge moment for the company @mdanderson.bsky.social will be running the trials. Good luck and hopefully we will soon have one more weapon against cancer!

010